Involvement of NF-kappaB transcription factor in the antiinflammatory activity of thymic peptides.
Novoselova
E G
EG
Institute of Cell Biophysics, Institutskaya ul. 3, Pushchino, Moscow oblast, 142290 Russia.
Lunin
S M
SM
Khrenov
M O
MO
Novoselova
T V
TV
Fesenko
E E
EE
D000818:Animals; D001284:Atrophy / Q000209:etiology / Q000473:pathology / Q000517:prevention & control; D016207:Cytokines / Q000097:blood; D007249:Inflammation / Q000097:blood / Q000150:complications / Q000473:pathology / Q000517:prevention & control*; D018836:Inflammation Mediators / Q000494:pharmacology*; D008070:Lipopolysaccharides / Q000494:pharmacology; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D016328:NF-kappa B / Q000378:metabolism*; D010766:Phosphorylation / Q000187:drug effects; D013154:Spleen / Q000187:drug effects / Q000378:metabolism; D013935:Thymic Factor, Circulating / Q000494:pharmacology; D016305:Thymopentin / Q000494:pharmacology; D013950:Thymus Gland / Q000187:drug effects / Q000473:pathology; D013951:Thymus Hormones / Q000494:pharmacology*
D016207:Cytokines; D018836:Inflammation Mediators; D008070:Lipopolysaccharides; D016328:NF-kappa B; D013951:Thymus Hormones; D013935:Thymic Factor, Circulating; D016305:Thymopentin